This amplification has been noted in several types of cancer, with the highest frequency of PD-L1 copy number alterations (CNAs) evident in primary mediastinal B-cell lymphoma, Hodgkin lymphoma and triple-negative breast cancer (TNBC) at approximately 63%, 40% and 29%, respectively [30,31,32]. The gene discussed is CD274; the disease is Hodgkins lymphoma.